Marc A. Cohen - 02 Jul 2021 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Shoaib Ghias, Attorney-in-Fact
Issuer symbol
CCCC
Transactions as of
02 Jul 2021
Net transactions value
+$20,734
Form type
4
Filing time
07 Jul 2021, 16:30:44 UTC
Previous filing
21 Jun 2021
Next filing
05 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Award $20,734 +522 +8.5% $39.72 6,641 02 Jul 2021 Direct F1, F2, F3
holding CCCC Common Stock 1,967,622 02 Jul 2021 By Marc Andrew Cohen Revocable Trust F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
F2 The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 2, 2021.
F3 This amount has been adjusted to reflect 92,817 shares previously transferred from the Reporting Person to the Marc Andrew Cohen Revocable Trust.
F4 Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust.